Clinical Trial Update: Evaluation of Continuous Symptom Treatment of ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating continuous symptom treatment for Attention Deficit Hyperactivity Disorder. Sponsor: Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED